What is MaxCyte, Inc. Common Stock's Market Cap?

MaxCyte, Inc. Common Stock's Market Cap is $131.6M, based on as-reported figures from SEC (XBRL) filings.

What is MaxCyte, Inc. Common Stock's Enterprise Value?

MaxCyte, Inc. Common Stock's Enterprise Value is $25.9M, based on as-reported figures from SEC (XBRL) filings.

What is MaxCyte, Inc. Common Stock's Price / Sales?

MaxCyte, Inc. Common Stock's Price / Sales is 4.2×, based on as-reported figures from SEC (XBRL) filings.

What is MaxCyte, Inc. Common Stock's EV / Revenue?

MaxCyte, Inc. Common Stock's EV / Revenue is 0.8×, based on as-reported figures from SEC (XBRL) filings.

What is MaxCyte, Inc. Common Stock's EV / EBITDA?

MaxCyte, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.

What is MaxCyte, Inc. Common Stock's Revenue (TTM)?

MaxCyte, Inc. Common Stock's Revenue (TTM) is $31.1M, based on as-reported figures from SEC (XBRL) filings.

What is MaxCyte, Inc. Common Stock's Net Income (TTM)?

MaxCyte, Inc. Common Stock's Net Income (TTM) is -$35.6M, based on as-reported figures from SEC (XBRL) filings.

What is MaxCyte, Inc. Common Stock's EBITDA?

MaxCyte, Inc. Common Stock's EBITDA is -$37.6M, based on as-reported figures from SEC (XBRL) filings.

What is MaxCyte, Inc. Common Stock's Diluted EPS (TTM)?

MaxCyte, Inc. Common Stock's Diluted EPS (TTM) is -0.35, based on as-reported figures from SEC (XBRL) filings.

What is MaxCyte, Inc. Common Stock's EBITDA Margin?

MaxCyte, Inc. Common Stock's EBITDA Margin is -121.2%, based on as-reported figures from SEC (XBRL) filings.

MaxCyte, Inc. Common Stock (MXCT) Financial Statements

MaxCyte, Inc. Common Stock

SIC 8731 · SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH

FIGI BBG00CFTQNG7

XNAS · usd

1.28▼ 0.01 (-0.39%)

As of 2026-09-08

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales

EV / Revenue

EV / EBITDA

Financial Highlights

Revenue (TTM)

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin

Net Debt

Trading Information

Previous Close1.28

Day's Range1.25 – 1.29

52-Week Range0.64 – 1.87

Volume432.8K

Avg Volume743.3K

Share Statistics

Shares Outstanding

Employees91

ExchangeXNAS

Listed2019-12-05

Share count as of August 7, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about MaxCyte, Inc. Common Stock (MXCT)

What is MaxCyte, Inc. Common Stock's Market Cap?: MaxCyte, Inc. Common Stock's Market Cap is $131.6M, based on as-reported figures from SEC (XBRL) filings.
What is MaxCyte, Inc. Common Stock's Enterprise Value?: MaxCyte, Inc. Common Stock's Enterprise Value is $25.9M, based on as-reported figures from SEC (XBRL) filings.
What is MaxCyte, Inc. Common Stock's Price / Sales?: MaxCyte, Inc. Common Stock's Price / Sales is 4.2×, based on as-reported figures from SEC (XBRL) filings.
What is MaxCyte, Inc. Common Stock's EV / Revenue?: MaxCyte, Inc. Common Stock's EV / Revenue is 0.8×, based on as-reported figures from SEC (XBRL) filings.
What is MaxCyte, Inc. Common Stock's EV / EBITDA?: MaxCyte, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is MaxCyte, Inc. Common Stock's Revenue (TTM)?: MaxCyte, Inc. Common Stock's Revenue (TTM) is $31.1M, based on as-reported figures from SEC (XBRL) filings.
What is MaxCyte, Inc. Common Stock's Net Income (TTM)?: MaxCyte, Inc. Common Stock's Net Income (TTM) is -$35.6M, based on as-reported figures from SEC (XBRL) filings.
What is MaxCyte, Inc. Common Stock's EBITDA?: MaxCyte, Inc. Common Stock's EBITDA is -$37.6M, based on as-reported figures from SEC (XBRL) filings.
What is MaxCyte, Inc. Common Stock's Diluted EPS (TTM)?: MaxCyte, Inc. Common Stock's Diluted EPS (TTM) is -0.35, based on as-reported figures from SEC (XBRL) filings.
What is MaxCyte, Inc. Common Stock's EBITDA Margin?: MaxCyte, Inc. Common Stock's EBITDA Margin is -121.2%, based on as-reported figures from SEC (XBRL) filings.